INVESTOR
RELATIONS
INVESTOR
RELATIONS
2023.02.10
Financial Reports
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2023 (Nine Months Ended December 31, 2022)
2023.01.26
Timely Disclosure
Announcement of Forecast for Dividend Increase and Commemorative Dividend
2023.01.10
Timely Disclosure
Start of Joint Research Using Medical Big Data for Treating Broken Bones
2023.01.06
Timely Disclosure
Notice of Establishment of Subsidiary
2023.01.05
Timely Disclosure
Notice of New Other Affiliated Company
2023.02.10
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2023 (Nine Months Ended December 31, 2022)
2022.11.10
Summary of Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2023 (Six Months Ended September 30, 2022)
2022.08.10
Summary of Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2023 (Three Months Ended June 30, 2022)